BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 18477344)

  • 1. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
    Tsochatzis E; Manolakopoulos S; Papatheodoridis GV; Hadziyannis E; Triantos C; Zisimopoulos K; Goulis I; Tzourmakliotis D; Akriviadis E; Manesis EK; Archimandritis AJ
    Aliment Pharmacol Ther; 2009 Nov; 30(9):947-54. PubMed ID: 19604179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.
    Petta S; Cammà C; DI Marco V; Calvaruso V; Enea M; Bronte F; Butera G; Cabibi D; Craxì A
    Aliment Pharmacol Ther; 2009 Sep; 30(6):603-13. PubMed ID: 19563503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
    Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.
    Ashour E; Samy N; Sayed M; Imam A
    Clin Lab; 2010; 56(3-4):103-10. PubMed ID: 20476641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
    Vidali M; Tripodi MF; Ivaldi A; Zampino R; Occhino G; Restivo L; Sutti S; Marrone A; Ruggiero G; Albano E; Adinolfi LE
    J Hepatol; 2008 Mar; 48(3):399-406. PubMed ID: 18164507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.